Researchers report that adjuvant (post-surgical) trastuzumab emtansine (T-DM1) treatment of women with high-risk HER2-positive breast cancer has reduced their long-term risk of death or invasive disease by 46%… read more.
Radiation monotherapy is an effective noninvasive treatment for oligometastatic renal cell carcinoma (RCC), researchers reported on Oct. 28, 2021 in The Lancet Oncology. “These findings are exciting because… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
